Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SULT1C2P2 designates a pseudogene within the cytosolic sulfotransferase family 1C. Unlike functional SULT enzymes—which catalyze the sulfation of hormones, neurotransmitters, drugs, and other xenobiotics[1][2][4]—SULT1C2P2 does not encode an active enzyme and lacks characterized function or clinical relevance. The presence of "pseudogene" in its name indicates it arises via gene duplication or mutation and is not transcribed or translated into a functional protein. No roles in metabolism, disease, drug interaction, or biomarker utility have been attributed to SULT1C2P2[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sulfotransferase family cytosolic 1C member 2 pseudogene 2 (SULT1C2P2).